Login to Your Account

Pharma: Other News To Note

Thursday, October 4, 2012
• Sanofi SA, of Paris, and Bristol-Myers Squibb Co. (BMS), of New York, restructured their long-term alliance following the loss of exclusivity of Plavix (clopidogrel bisulfate) and Avapro (irbesartan)/Avalide (irbesartan-hydrochlorothiazide) in most markets.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription